Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/44707
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRodríguez Barrios, José Manuel-
dc.contributor.authorPérez Alcántara, Ferran-
dc.contributor.authorCrespo Palomo, Carlos-
dc.contributor.authorGonzález García, Paloma-
dc.contributor.authorAntón de las Heras, Enrique-
dc.contributor.authorBrosa, Max-
dc.date.accessioned2013-07-10T11:48:01Z-
dc.date.available2013-07-10T11:48:01Z-
dc.date.issued2012-12-
dc.identifier.issn1618-7598-
dc.identifier.urihttp://hdl.handle.net/2445/44707-
dc.description.abstractThe objective of this study was to evaluate the methodological characteristics of cost-effectiveness evaluations carried out in Spain, since 1990, which include LYG as an outcome to measure the incremental cost-effectiveness ratio. METHODS: A systematic review of published studies was conducted describing their characteristics and methodological quality. We analyse the cost per LYG results in relation with a commonly accepted Spanish cost-effectiveness threshold and the possible relation with the cost per quality adjusted life year (QALY) gained when they both were calculated for the same economic evaluation. RESULTS: A total of 62 economic evaluations fulfilled the selection criteria, 24 of them including the cost per QALY gained result as well. The methodological quality of the studies was good (55%) or very good (26%). A total of 124 cost per LYG results were obtained with a mean ratio of 49,529<euro> and a median of 11,490<euro> (standard deviation of 183,080). Since 2003, a commonly accepted Spanish threshold has been referenced by 66% of studies. A significant correlation was found between the cost per LYG and cost per QALY gained results (0.89 Spearman-Rho, 0.91 Pearson). CONCLUSIONS: There is an increasing interest for economic health care evaluations in Spain, and the quality of the studies is also improving. Although a commonly accepted threshold exists, further information is needed for decision-making as well as to identify the relationship between the costs per LYG and per QALY gained.-
dc.format.extent44 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSpringer Verlag-
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1007/s10198-011-0326-y-
dc.relation.ispartofEuropean Journal of Health Economics, 2012, vol. 13, num. 6, p. 723-740-
dc.relation.urihttp://dx.doi.org/10.1007/s10198-011-0326-y-
dc.rights(c) Springer Verlag, 2012-
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)-
dc.subject.classificationAnàlisi econòmica-
dc.subject.classificationEconomia de la salut-
dc.subject.classificationEspanya-
dc.subject.otherEconomic analysis-
dc.subject.otherMedical economics-
dc.subject.otherSpain-
dc.titleThe use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec613543-
dc.date.updated2013-07-10T11:48:01Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Genètica, Microbiologia i Estadística)

Files in This Item:
File Description SizeFormat 
613543.pdf906.1 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.